Herbalife (HLF) On Raised 2026 Guidance And CFO Change Looks Undervalued
Herbalife (HLF) is back in focus after revising its full year 2026 net sales guidance upward and announcing a planned CFO transition. These developments give investors fresh information on both outlook and leadership.
See our latest analysis for Herbalife.
Herbalife’s latest guidance and CFO transition sit against a mixed price picture, with the 7-day share price return of 7.03% and 1-year total shareholder return of 34.46% contrasting with a decline of 75.16% over five years on a total shareholder return basis.
If Herbalife’s recent guidance change has you rethinking where growth stories might emerge next, it could be a good moment to scan 21 top founder-led companies
With Herbalife shares rebounding in the short term but still far below their 5 year level, the key issue now is whether the current valuation still compensates you for the earnings swings and the leadership change that lies ahead.
Most Popular Narrative: 27.5% Undervalued
Compared with Herbalife's last close at $12.33, the most followed narrative sets fair value at $17.00, which frames the current debate around upside potential and execution risk.
The company continues to experience flat to declining volumes in several regions, with only modest improvements in constant currency net sales, indicating that the addressable market for Herbalife's traditional model may be reaching maturity and that top-line revenue growth could remain pressured.
Want to understand why this maturity concern still supports a higher value for Herbalife? The narrative leans on a specific mix of earnings growth, margin reset and a leaner future valuation multiple that might surprise you.
Result: Fair Value of $17.00 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, Herbalife still faces regulatory scrutiny of its multi level marketing model and evolving consumer preferences around supplements, which could challenge the earnings and margin narrative.
Find out about the key risks to this Herbalife narrative.
Next Steps
If the mixed tone around Herbalife leaves you unsure, now is a good time to review both sides of the story yourself. To consider the key risks and potential upsides in one place, start with the 3 key rewards and 5 important warning signs
Looking for more investment ideas beyond Herbalife?
If Herbalife has sharpened your focus on opportunities, do not stop here. Use the Simply Wall St Screener to spot other stocks that fit your style.
- Target potential mispricings by scanning companies that combine quality with value through the 52 high quality undervalued stocks.
- Prioritize resilience by checking stocks with stronger financial footing and efficient balance sheets in the solid balance sheet and fundamentals stocks screener (50 results).
- Hunt for lesser known opportunities with solid fundamentals using the screener containing 19 high quality undiscovered gems.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com